Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2002 3
2003 3
2004 1
2005 1
2006 4
2007 5
2008 5
2009 6
2010 2
2011 2
2012 4
2013 4
2014 5
2015 4
2016 9
2017 3
2018 11
2019 14
2020 9
2021 9
2022 7
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 37261360

101 results

Results by year

Filters applied: . Clear all
Page 1
Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation.
Faridi RM, Kemp TJ, Dharmani-Khan P, Lewis V, Tripathi G, Rajalingam R, Daly A, Berka N, Storek J, Masood Khan F. Faridi RM, et al. PLoS One. 2016 Jun 24;11(6):e0158242. doi: 10.1371/journal.pone.0158242. eCollection 2016. PLoS One. 2016. PMID: 27341514 Free PMC article.
The impact of donor and recipient KIR genes and KIR ligands on the occurrence of acute graft-versus-host disease and graft survival after HLA-identical sibling hematopoietic stem cell transplantation.
Hoseinian SA, Jafari D, Mahmoodi M, Alimoghaddam K, Ostadali M, Talebzadeh Bonakdar A, Foma AM, Yekaninejad MS, Amirzargar AA. Hoseinian SA, et al. Turk J Med Sci. 2018 Aug 16;48(4):794-804. doi: 10.3906/sag-1712-75. Turk J Med Sci. 2018. PMID: 30119155 Free article.
Haplotype Motif-Based Models for KIR-Genotype Informed Selection of Hematopoietic Cell Donors Fail to Predict Outcome of Patients With Myelodysplastic Syndromes or Secondary Acute Myeloid Leukemia.
Schetelig J, Baldauf H, Koster L, Kuxhausen M, Heidenreich F, de Wreede LC, Spellman S, van Gelder M, Bruno B, Onida F, Lange V, Massalski C, Potter V, Ljungman P, Schaap N, Hayden P, Lee SJ, Kröger N, Hsu K, Schmidt AH, Yakoub-Agha I, Robin M. Schetelig J, et al. Front Immunol. 2021 Jan 19;11:584520. doi: 10.3389/fimmu.2020.584520. eCollection 2020. Front Immunol. 2021. PMID: 33542712 Free PMC article.
Prediction of NK Cell Licensing Level in Selection of Hematopoietic Stem Cell Donor, Initial Results.
Rogatko-Koroś M, Mika-Witkowska R, Bogunia-Kubik K, Wysoczańska B, Jaskuła E, Kościńska K, Nestorowicz K, Dziopa J, Szlendak U, Gwozdowicz S, Graczyk-Pol E, Lange A, Nowak J. Rogatko-Koroś M, et al. Arch Immunol Ther Exp (Warsz). 2016 Dec;64(Suppl 1):63-71. doi: 10.1007/s00005-016-0438-2. Epub 2016 Dec 8. Arch Immunol Ther Exp (Warsz). 2016. PMID: 27933342 Free article.
Haploidentical Natural Killer Cells Infused before Allogeneic Stem Cell Transplantation for Myeloid Malignancies: A Phase I Trial.
Lee DA, Denman CJ, Rondon G, Woodworth G, Chen J, Fisher T, Kaur I, Fernandez-Vina M, Cao K, Ciurea S, Shpall EJ, Champlin RE. Lee DA, et al. Biol Blood Marrow Transplant. 2016 Jul;22(7):1290-1298. doi: 10.1016/j.bbmt.2016.04.009. Epub 2016 Apr 16. Biol Blood Marrow Transplant. 2016. PMID: 27090958 Free PMC article. Clinical Trial.
101 results